JP2021503451A5 - - Google Patents

Download PDF

Info

Publication number
JP2021503451A5
JP2021503451A5 JP2020526523A JP2020526523A JP2021503451A5 JP 2021503451 A5 JP2021503451 A5 JP 2021503451A5 JP 2020526523 A JP2020526523 A JP 2020526523A JP 2020526523 A JP2020526523 A JP 2020526523A JP 2021503451 A5 JP2021503451 A5 JP 2021503451A5
Authority
JP
Japan
Prior art keywords
administration
pharmaceutical composition
pharmaceutically acceptable
composition according
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020526523A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021503451A (ja
JP7038437B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/058848 external-priority patent/WO2019097381A1/en
Publication of JP2021503451A publication Critical patent/JP2021503451A/ja
Publication of JP2021503451A5 publication Critical patent/JP2021503451A5/ja
Application granted granted Critical
Publication of JP7038437B2 publication Critical patent/JP7038437B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020526523A 2017-11-17 2018-11-10 眼障害及び皮膚疾患の処置のための化合物、組成物、及び方法 Expired - Fee Related JP7038437B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN201741041231 2017-11-17
IN201741041231 2017-11-17
IN201841032406 2018-08-29
IN201841032406 2018-08-29
PCT/IB2018/058848 WO2019097381A1 (en) 2017-11-17 2018-11-10 Compounds, compositions and methods for treatment of eye disorders and skin diseases

Publications (3)

Publication Number Publication Date
JP2021503451A JP2021503451A (ja) 2021-02-12
JP2021503451A5 true JP2021503451A5 (https=) 2021-11-04
JP7038437B2 JP7038437B2 (ja) 2022-03-18

Family

ID=66538944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020526523A Expired - Fee Related JP7038437B2 (ja) 2017-11-17 2018-11-10 眼障害及び皮膚疾患の処置のための化合物、組成物、及び方法

Country Status (14)

Country Link
US (1) US11186561B2 (https=)
EP (1) EP3709982A4 (https=)
JP (1) JP7038437B2 (https=)
KR (1) KR102405239B1 (https=)
CN (1) CN111315369A (https=)
AU (1) AU2018369853B2 (https=)
BR (1) BR112020009364A2 (https=)
CA (1) CA3081482A1 (https=)
IL (1) IL274233B2 (https=)
MX (1) MX392359B (https=)
RU (1) RU2020119228A (https=)
SG (1) SG11202004078YA (https=)
WO (1) WO2019097381A1 (https=)
ZA (1) ZA202002075B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021003452A2 (pt) * 2018-08-29 2021-05-18 Cellix Bio Private Limited composto e composição farmacêutica
WO2020144546A1 (en) * 2019-01-12 2020-07-16 Cellix Bio Private Limited Combination of selective alpha-adrenergic receptor agonist or an anticholinergic agent and lipoic acid and uses thereof
JP7795555B2 (ja) * 2021-04-30 2026-01-07 ▲遠▼大医▲薬▼(中国)有限公司 近視を治療するための方法及び薬物組成物
CN118634218A (zh) 2023-05-24 2024-09-13 温州医科大学附属眼视光医院 一种有效延缓及治疗近视的药物组合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4512E (fr) * 1904-07-12 1905-08-26 Georges Albert Simon Weill Genre de lyre de construction économique pour suspensions de lampes
FR4512M (https=) * 1965-05-18 1966-10-17
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
IL113459A (en) 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
WO1999021537A1 (fr) 1997-10-28 1999-05-06 Bando Chemical Industries, Ltd. Feuille de timbre cutane et procede de production d'une feuille de base pour timbre
US6103275A (en) 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
DE19827732A1 (de) 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
US6312716B1 (en) 1999-05-10 2001-11-06 Peierce Management Llc Patch and method for transdermal delivery of bupropion base
US6974588B1 (en) 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
FR2832637B1 (fr) * 2001-06-07 2004-07-30 Lefaix Marie Therese Droy Utilisation d'un antioxydant pour la fabrication d'un medicament destine au traitement des affections oculaires de surface
ITMI20030831A1 (it) * 2003-04-22 2004-10-23 Laboratorio Chimico Int Spa Sale basico dell'acido tiottico con la l-carnitina.
CN101522658A (zh) * 2006-06-16 2009-09-02 因迪基恩药物公司 作为抗糖尿病药用于控制糖尿病高血糖症和糖尿病并发症的二甲双胍r-(+)硫辛酸盐
GB0724558D0 (en) * 2007-12-15 2008-01-30 Sharma Anant Optical correction
WO2010125416A1 (en) * 2009-04-27 2010-11-04 Raouf Rekik Drug delivery to the anterior and posterior segments of the eye
KR101586789B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
US8853259B2 (en) * 2013-02-07 2014-10-07 Banavara L. Mylari Metformin derivatives for treating diabetes and diabetes complications
CA2936146A1 (en) * 2014-01-06 2015-07-09 Stealth Biotherapeutics Corp Methods and compositions for preventing or treating dominant optic atrophy
CN104387364B (zh) * 2014-12-15 2016-11-16 南京工业大学 L-鸟氨酸硫辛酸复合盐及其制备方法和应用
EP3522873B1 (en) * 2016-10-04 2022-03-16 Cellix Bio Private Limited Compositions and methods for the treatment of xerostomia
CA3081553C (en) * 2017-11-17 2022-11-15 Cellix Bio Private Limited Compositions and methods for the treatment of eye disorders

Similar Documents

Publication Publication Date Title
JP2021503451A5 (https=)
JP2021503449A5 (https=)
JP2014511892A5 (https=)
JP2021512098A5 (https=)
JP2020509022A5 (https=)
JP2018021046A5 (https=)
JP2016534063A5 (https=)
JP2016519165A5 (https=)
JP2005523922A5 (https=)
JP2020512337A5 (https=)
JP2012521994A5 (https=)
JP2019535723A5 (https=)
JP2013542261A5 (https=)
JP2020507589A5 (https=)
JP2020502047A5 (https=)
JP2015508092A5 (https=)
JP2018513832A5 (https=)
JP2016529235A5 (https=)
JP2014530818A5 (https=)
JP2016510768A5 (https=)
JP2010514733A5 (https=)
JP2009040767A5 (https=)
IL274233B2 (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
JP2019151627A5 (https=)
JP2017039714A5 (https=)